ResMed Inc. (RMD)

Basic

  • Market Cap

    $23.2B

  • EV

    $24.48B

  • Shares Out

    147.1M

  • Revenue

    $4,375.02M

  • Employees

    10,140

Margins

  • Gross

    55.95%

  • EBITDA

    29.99%

  • Operating

    26.63%

  • Pre-Tax

    25.42%

  • Net

    20.72%

  • FCF

    18.61%

Returns (5Yr Avg)

  • ROA

    11.99%

  • ROE

    22.67%

  • ROCE

    22.47%

  • ROIC

    16.95%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $183.55

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $29.78

  • Earnings (Dil)

    $6.15

  • FCF

    $5.52

  • Book Value

    $28.9

Growth (CAGR)

  • Rev 3Yr

    13.05%

  • Rev 5Yr

    12.71%

  • Rev 10Yr

    11.06%

  • Dil EPS 3Yr

    9.7%

  • Dil EPS 5Yr

    21.53%

  • Dil EPS 10Yr

    10.98%

  • Rev Fwd 2Yr

    8.01%

  • EBITDA Fwd 2Yr

    10.95%

  • EPS Fwd 2Yr

    10.57%

  • EPS LT Growth Est

    8%

Dividends

  • Yield

    —

  • Payout

    29.17%

  • DPS

    $1.8

  • DPS Growth 3Yr

    4.89%

  • DPS Growth 5Yr

    4.56%

  • DPS Growth 10Yr

    9%

  • DPS Growth Fwd 2Yr

    7.78%

Select a metric from the list below to chart it

Jun '14
Jun '16
Jun '18
Jun '20
Jun '22
LTM
Metric
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
LTM

Total Revenues

2,606.6

2,957.0

3,196.8

3,578.1

4,223.0

4,375.0

Total Revenues % Chg.

11.4%

13.4%

8.1%

11.9%

18.0%

20.7%

Cost of Goods Sold, Total

1,070.0

1,189.6

1,307.4

1,514.2

1,836.9

1,927.2

Gross Profit

1,536.6

1,767.4

1,889.4

2,064.0

2,386.1

2,447.8

Selling General & Admin Expenses, Total

645.0

676.7

670.4

737.5

874.0

902.9

R&D Expenses

180.7

201.9

225.3

253.6

287.6

300.2

Amortization of Goodwill and Intangible Assets

74.9

79.7

76.2

70.7

72.4

79.5

Other Operating Expenses, Total

900.6

958.3

971.9

1,061.8

1,234.1

1,282.6

Operating Income

636.0

809.1

917.6

1,002.2

1,152.0

1,165.3

Interest Expense, Total

-36.2

-39.4

-23.6

-22.3

-47.4

-58.2

Interest And Investment Income

2.3

—

—

—

—

—

Net Interest Expenses

-33.9

-39.4

-23.6

-22.3

-47.4

-58.2

Income (Loss) On Equity Invest.

-15.8

-25.1

-11.2

-8.5

-7.3

-9.1

Currency Exchange Gains (Loss)

1.7

—

-0.8

2.8

-4.2

-1.2

Other Non Operating Income (Expenses)

2.6

2.4

1.1

0.4

-1.5

2.6

EBT, Excl. Unusual Items

590.6

747.0

883.0

974.5

1,091.6

1,099.4

Restructuring Charges

-9.4

—

-13.9

—

-9.2

-9.2

Merger & Related Restructuring Charges

-6.1

—

—

-1.9

-10.9

-10.9

Gain (Loss) On Sale Of Investments

-15.0

-14.5

14.5

-12.2

9.9

12.6

Insurance Settlements

—

—

—

—

20.2

20.2

Legal Settlements

-41.2

0.6

—

—

—

—

EBT, Incl. Unusual Items

518.8

733.1

883.7

960.5

1,101.7

1,112.1

Income Tax Expense

114.3

111.4

409.2

181.0

204.1

205.6

Earnings From Continuing Operations

404.6

621.7

474.5

779.4

897.6

906.5

Net Income

404.6

621.7

474.5

779.4

897.6

906.5

Net Income to Common Incl Extra Items

404.6

621.7

474.5

779.4

897.6

906.5

Net Income to Common Excl. Extra Items

404.6

621.7

474.5

779.4

897.6

906.5

Total Shares Outstanding

143.7

144.9

145.6

146.4

147.1

147.1

Weighted Avg. Shares Outstanding

143.1

144.3

145.3

146.1

146.8

146.9

Weighted Avg. Shares Outstanding Dil

144.5

145.7

146.5

147.0

147.5

147.5

EPS

2.8

4.3

3.3

5.3

6.1

6.2

EPS Diluted

2.8

4.3

3.2

5.3

6.1

6.1

EBITDA

752.9

922.9

1,029.0

1,126.2

1,292.1

1,312.2